Copyright
©The Author(s) 2019.
World J Gastrointest Pharmacol Ther. Jan 21, 2019; 10(1): 22-28
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.22
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.22
Figure 1 Rates of opioid use and misuse.
Patients with ulcerative colitis and concomitant functional gastrointestinal disease had higher rates of prescription opioid use (36% vs 9%; aP < 0.0001) and opioid misuse (13% vs 1%; bP < 0.001). UC: Ulcerative colitis; FGID: Functional gastrointestinal disease.
- Citation: Chitnavis MV, Baray M, Northup PG, Tuskey AG, Behm BW. Opioid use and misuse in ulcerative colitis. World J Gastrointest Pharmacol Ther 2019; 10(1): 22-28
- URL: https://www.wjgnet.com/2150-5349/full/v10/i1/22.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v10.i1.22